CTMX CYTOMX THERAPEUTICS INC Capital Structure Changes 8-K Filing 2023 - Equity Offerings On June 29, 2023, CytomX Therapeutics, Inc. entered into a unit purchase agreement with certain accredited investors, proposing a sale and issuance of pre-funded warrants to purchase up to 14,423,077 shares of the company's common stock along with Tranche 1 and 2 Warrants to purchase up to 5,769,231 shares of Common Stock each. The closing of the Private Placement is expected to occur on July 3, 2023 and the gross proceeds to the company from this offering are approximately $30.0 million.Get access to all SEC 8-K filings of the CYTOMX THERAPEUTICS INC